KALA BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.816 USD | -1.21% |
|
-1.78% | -2.62% |
| Apr. 02 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
| Mar. 29 | KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA BIO, INC. | Other Pharmaceuticals | -1.21% | -1.78% | -2.62% | -58.13% | -97.69% | 19.43M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- KALA Stock
- Charts KALA BIO, Inc.
- Comparison Chart